ArticleMolecular oncology2020

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes.

Miroslav Pribyl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.